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Abstract 
Background and purpose. Activation of GABAB receptors in the dentate gyrus (DG) 
enhances granule cell (GC) activity by reducing synaptic inhibition imposed by hilar 
interneurons. This disinhibitory action facilitates signal transfer from the perforant 
path to the hippocampus. However, as the two main molecular subtypes, GABAB(1a,2) 
and GABAB(1b,2) receptors, prefer axonal terminal and dendritic compartments, 
respectively, they may modulate the hilar pathways at different synaptic localisations. 
We examined their relative expression and functions in the DG.  
Experimental approach. The localisation of GABAB subtypes was revealed 
immunohistochemically using subunit-selective antibodies in GABAB1a
-/- and 
GABAB1b
-/- mice. Effects of subtype activation by the GABAB receptor agonist, 
baclofen, were examined on the perforant path-stimulated GC population activities in 
brain slices.  
Key results. GABAB(1a,2) receptors were concentrated in the inner molecular layer, 
the neuropil of the hilus and hilar neurons at the border zone; while GABAB(1b,2) 
receptors dominated the outer molecular layer and hilar neurons in the deep layer, 
showing their differential localisation in the GC dendritic area and the hilus. Baclofen 
enhanced the GC population spike to a larger extent in the GABAB1b
-/- mice, 
demonstrating exclusively disinhibitory roles of the GABAB(1a,2) receptors. 
Conversely, in the GABAB1a
-/- mice baclofen not only enhanced but also inhibited the 
population spike during GABAA blockade, revealing both disinhibitory and inhibitory 
effects by GABAB(1b,2) receptors. 
Conclusions and implications: The GABAB(1a,2) and GABAB(1b,2)  receptor subtypes 
differentially modulate GC outputs via selective axonal terminal and dendritic 
locations in the hilar pathways. The GABAB(1a,2) receptors exclusively mediate 
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disinhibition, thereby playing a greater role in gating signal transfer for hippocampal 
spatial and pattern learning. 
 
Key words: disinhibition, GABAB receptors, baclofen, GABAB1a, GABAB1b, 
multi-electrode, dentate gyrus 
 
Abbreviations: 
1a-/-: GABAB1a knockout 
1b-/-: GABAB1b knockout 
CCK: cholecystokinin 
CGP55845: (2S)-3-[[(1S)-1-(3,4-Dichlorophenyl)ethyl]amino-2-
hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride 
CNQX: 6-cyano-7-nitroquinoxaline-2,3-dione 
DG: dentate gyrus 
fEPSP: field excitatory postsynaptic potential 
GABA: gamma-amino butyric acid 
GC: granule cell 
HICAP: Hilar Commissural-Associational Pathway related cells 
HIPP: Hilar Perforant Path related cells  
IM: inner molecular layer 
OM: outer molecular layer 
PP: perforant path  
PS: population spike 
WT: wild-type 
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Introduction 
GABAB receptors are G-protein-coupled receptors for the main inhibitory 
neurotransmitter, GABA (gamma-amino butyric acid). They participate in many brain 
functions including cognition, reward and anxiety via modulation of synaptic 
transmission (Bowery et al., 2002; Bettler et al., 2004). Activation of pre-synaptic 
GABAB receptors decreases neurotransmitter release by inhibiting voltage-gated Ca
2+ 
channels and vesicular release; activation of somatodendritic GABAB receptors 
modulates Ca2+ channels and G-protein coupled inward-rectifying K+ channels, 
resulting in postsynaptic inhibition. However, presynaptic GABAB receptors at 
excitatory and inhibitory synapses in neuronal networks induce inhibitory and 
disinhibitory effects, respectively. GABAB receptor activation in the hippocampal 
CA1 and CA3 synaptic circuits is predominantly inhibitory because of the inhibition 
of glutamate release via presynaptic heteroreceptors (Nicoll, 2004; Chen et al., 2006). 
Conversely, in the dentate gyrus (DG), GABAB receptors primarily exert disinhibition 
on granule cells (GCs) as GABA release from hilar interneurons is reduced (Burgard 
& Sarvey, 1991; Mott & Lewis, 1991; Mott et al., 1993).  
 
The disinhibitory role of GABAB receptors is important for the gate control of inputs 
from the entorhinal cortex to the hippocampus for spatial and pattern learning (Gilbert 
et al., 2001; Leutgeb et al., 2007; Moser et al., 2008). The perforant path (PP) forms 
excitatory synapses on dendrites of GCs, and spikes generated in GCs propagate into 
the hippocampus. However, the GCs are strongly inhibited by a divergent population 
of local interneurons in the hilus and the molecular layer (Freund & Buzsaki, 1996; 
Scharfman & Witter, 2007), which release GABA to activate ionotropic GABAA and 
metabotropic GABAB receptors on GCs and induce fast and slow inhibitory currents 
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(Otis & Mody, 1992; Otis et al., 1993). Hilar interneurons in the border zone are 
particularly important for this role because they project to perisomatic and proximal 
dendritic regions (Freund & Buzsaki, 1996; Amaral et al., 2007), exerting synaptic 
inhibition that shunts action potential generation (Ben-Ari et al., 2005). GABAB 
receptors are densely expressed in hilar interneurons (Bischoff et al., 1999; Kulik et 
al., 2003), and activation of these somatodendritic receptors decreases firing of hilar 
border neurons (Mott et al., 1999), reduces GABA release on GCs and enhances spike 
discharge (Burgard & Sarvey, 1991; Mott & Lewis, 1991; Mott et al., 1993).  
However, presynaptic GABAB receptors may also reduce hilar inhibition by 
decreasing excitatory inputs to the hilus and inhibiting GABA release from hilar 
axonal terminals on to GCs.  
 
Pre- and postsynaptic GABAB receptors show molecular diversity (Ulrich & Bettler, 
2007; Pinard et al., 2010). GABAB(1a,2) and GABAB(1b,2) receptors are the two main 
molecular subtypes, assembled by the obligatory hetero-dimerisation between the 
GABAB1 isoforms, 1a and 1b, and the GABAB2 subunit. They show no significant 
pharmacological or signalling differences, but their expression is independently 
regulated in neuronal populations and differs between synaptic compartments 
(Bischoff et al., 1999; Fritschy et al., 1999; Margeta-Mitrovic et al., 1999; Vigot et al., 
2006). At glutamatergic synapses, the GABAB(1a,2) receptors are preferentially 
expressed in presynaptic compartments, directed exclusively by the N-terminal 
“sushi” domains on the 1a subunit; while the GABAB(1b,2) receptors, lacking the 
“sushi” domains, are primarily confined at the default dendritic location (Vigot et al., 
2006; Tiao et al., 2008; Biermann et al., 2010). The GABAB(1a,2) receptors are also the 
exclusive presynaptic autoreceptors inhibiting GABA release between layer 1 and 5 
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cortical neurons, with the GABAB(1b,2) receptors at the dendrite (Perez-Garci et al., 
2006). However, the GABAB(1b,2) receptors can also inhibit GABA release in the CA1 
(Vigot et al., 2006) and the thalamus (Ulrich et al., 2007), probably via 
somatodendritic inhibition of interneurons.  
 
Both 1a and 1b transcripts are expressed in hilar neurons and GCs in the DG, but high 
density receptor expression is shown in the molecular layer and the hilus with the 
relative expression of two receptor subtypes unclear (Bischoff et al., 1999). Although 
somatodendritic GABAB  receptors on the hilar border neurons, presumably of the 
GABAB(1b,2) subtype, mediate disinhibition (Mott et al., 1999), genetic deletion of the 
1a, but not 1b isoform, impairs synaptic plasticity in the hippocampus and novel 
object recognition performance of the GABAB1a
-/-
 mice (Vigot et al., 2006; Jacobson 
et al., 2007), implicating a critical role for the GABAB(1a,2) receptors in pattern 
learning. We tested the hypothesis that GABAB(1a,2) receptors exert greater 
disinhibition on GCs by presynaptic heteroreceptor inhibition of excitatory inputs to 
the hilus and autoreceptor inhibition of GABA release on GC dendrites in the 
molecular layer. We, therefore, examined the anatomical localisation of the GABAB 
subtypes in the DG of the GABAB1a
-/-
 and GABAB1b
-/- mice, and investigated their 
individual roles in modulating GC output. 
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Materials and Methods 
The use of animals was in accordance with the Animals in Scientific Procedures Act 
(1986) UK. GABAB1a knockout mice (1a-/-), GABAB1b knockout mice (1b-/-) and 
their wild-type (WT) littermates were bred from heterozygous pairs and maintained 
on a Balb/c background (Vigot et al., 2006). The transgenic mice were back-crossed 
with WT Balb/c mice (B & K Universal, Hull, Yorkshire, UK) every three 
generations. Animals were group-housed with food and water available ad libitum in 
a room with temperature control (23 ± 0.5oC) and a 12/12 hour light/dark cycle. The 
genotypes of the mice were determined at approximately 5 weeks of age by PCR on 
DNA extracts from tail biopsies. Sequences of the primers used in genotyping were as 
described previously (Vigot et al., 2006). Male mice (aged 5 - 12 weeks) exhibited no 
spontaneous seizures or other basal behavioural abnormalities (Jacobson et al., 2006), 
in contrast to the GABAB1-/- knockout mice that displayed several forms of complex 
seizures (Schuler et al., 2001). The use of drug and molecular target nomenclature is 
conformed to Guide to Receptors and Channels (Alexander et al., 2011). 
 
Electrophysiological recordings of synaptic potentials in dentate GCs using a multi-
electrode array 
Sagittal sections of both brain hemispheres were cut at a thickness of 300 µm using a 
vibratome (Series 1000, Vibratome, St. Louis, Missouri, USA, or a Leica VT1200, 
Leica Microsystems GmbH, Wetzlar, Germany). Transverse sections of the DG and 
the hippocampus were harvested and transferred to oxygenated (5% CO2 / 95% O2) 
artificial cerebrospinal fluid, which contained (in mM) NaCl (123), Na2CO3 (25), 
glucose (10), KCl (3.7), CaCl2 (2.5), NaH2PO4 (1.4) and MgSO4 (1.2), and maintained 
at 31°C. One slice was transferred to a multi-electrode probe (MED-P210A; MED64, 
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Alpha MED Sciences, Osaka, Japan), which consists of 64 indium tin oxide and 
platinum black electrodes arranged in an 8 by 8 grid with an inter-electrode distance 
of 100 µm. Slices were orientated with a row of electrodes in line with the GC layer 
of the inner, enclosed blade of the DG (Fig. 3A) and held in place using a nylon mesh 
and a platinum ring. Bath perfusion was at a rate of 1-2 ml/min and the artificial 
cerebrospinal fluid was continuously oxygenated (5% CO2 / 95% O2), and heated to 
31±0.5°C using an in-line heater (Warner Instruments, Hamden, Connecticut, USA). 
 
Electrical pulses (0.2 ms in duration) were delivered every 60s to stimulate the PP via 
one of the electrodes in the array positioned in the outer two thirds of the molecular 
layer. Stimulation, recording and the analysis of extracellular potentials was 
performed using the Mobius software (version 0.3.7; Alpha MED Sciences, Osaka, 
Japan). The negatively deflected field excitatory postsynaptic potentials (fEPSPs) 
were recorded in the dendrite field of GCs in the outer molecular layer. Signals with 
amplitude greater than 200 µV were captured and used for off-line analysis. Due to 
submerged perfusion method and the low impedance of the surface electrodes (Chen 
et al., 2006), the amplitude of the field potentials recorded by multi-electrodes are 
small, but the cut-off amplitude was more than 3 times the peak-to-peak noise level. 
The fEPSP slope was measured using the 10–90% slope function and the absolute 
value (mV/ms) was used to assess the excitatory synaptic strength.  
 
The population spike (PS) was recorded from the soma of the GCs where the field 
potential waveform displayed positively deflected fEPSP superimposed by a large 
negatively-deflected spike. The relative amplitudes of the fEPSP and the spike differ 
between recording sites. Recordings towards the hilar region displayed a relatively 
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larger fEPSP as the site gets closer to the current source. Therefore, all PSs with 
amplitudes larger than 500 µV were analysed. The amplitude of the PS (mV) was 
measured from the negative peak to the line connecting the positive peaks for the 
summation of synchronised action potentials from the GCs. The initial slope of the 
positively-deflected fEPSP was also measured by the 10–90% slope function 
(mV/ms), which mirrors the negative fEPSP slope of the same neuronal population as 
an evaluation of excitatory synaptic strength. The area-under-the-curve (mV*ms, PS 
area) was calculated including any additional spikes at longer latencies induced by 
drug treatment to evaluate the ensemble effect of all events. The input-output 
relationship was examined in all slices using escalating stimulation intensities (10 to 
110 µA in steps of 10 µA), and approximately 80% of the maximum responses was 
used for further pharmacological studies.  
 
Effects of GABAB receptor agonist and antagonist were examined by bath application 
following a 30 minute baseline recording (control). Recordings from 3 to 10 
electrodes were analysed independently and the mean drug effect was obtained for 
each slice. This exercise averages out variability between different recording sites and 
hence enhances the reproducibility of pharmacological effects between experiments 
(Chen et al., 2006). In addition, the effects of GABAB receptor agonist and antagonist 
were similar on fEPSPs and PSs elicited by different stimulating electrodes in the 
molecular layer to recruit the lateral or medial perforant path, respectively, so that the 
data sets were pooled. There was also no apparent age (5-12 weeks)-dependent effect.  
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Immunohistochemical staining and analysis 
The specificity of the anti-GABAB2 antibody (AB5394; Millipore Ltd.) has been 
confirmed using the GABAB2-/- mice (Gassmann et al., 2004). The anti-GABAB1 
antibody (sc-14006; Santa Cruz Biotechnology Inc.) was raised against the 
immunogen sequence specific for GABAB1 subunit (NCBI mouse protein library) and 
the immunostaining produced the same pattern of subunit distribution in the 
hippocampus and the DG as shown in previous studies (Kulik et al., 2003; Vigot et al., 
2006). Notably, GABAB1 staining in the stratum lucidum of the CA3 area was 
significantly reduced in the 1a-/- mice (Vigot et al., 2006).  
 
The brain block containing the DG was fixed in ice-cold paraformaldehyde (4%) for 4 
hours immediately following decapitation. Antigen retrieval was carried out by 
heating the tissue in sodium citrate buffer for 130s in a 750W microwave oven, as 
described by Fritschy et al. (1999). Coronal sections of 30 µm thick were cut in a 
cryostat (Microtome, UK) at -21°C, and incubated overnight (approximately 15 hours) 
at 4 °C with primary antibodies raised against either the GABAB1 or the GABAB2 
subunit. The bound primary antibodies were labelled with biotinylated secondary 
antibodies (Jackson Immuno Research Laboratories Inc, West Grove, Pennsylvania, 
USA). The tissue-bound biotin molecules were then labelled with a peroxidase-avidin 
complex (Vectastain ABC Kit, Vector Laboratories Ltd., Peterborough, 
Cambridgeshire, United Kingdom) in PBS with 0.5 % Triton X-100 (v/v) for 30 
minutes. Sections were then stained using DAB (3, 3’-diaminobenzidine, ImmPACT 
DAB Substrate; Vector Laboratories Ltd.) under visual guidance. Negative control 
sections were incubated without the primary antibodies to evaluate any unspecific 
binding by the secondary antibody.  
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Brain tissues from each of the three genotypes (WT, 1a-/- and 1b-/-) were processed 
simultaneously to minimise variability in staining intensity. The Nissl stain was also 
performed to examine the architectonic structure of the tissue in the knockout mice. 
Images were captured using a Nikon light microscope with a fitted digital camera 
(DS-2Mvm, Nikon Instruments Europe, Kingston, UK). The number of stained hilar 
neurons was counted in each section. The hilar border neurons were those located in a 
single cell layer immediately adjacent to the GC layer. The deep layer neurons were 
those in between the upper and lower border layers, excluding the CA4 area. The 
relative staining intensities of the neuropil of the molecular layers were scored at high 
(3), medium (2), low (1) and very low (0) levels within the same batch of staining. 
The mean for each DG was obtained from 8 – 20 sections across the septotemporal 
axis and used for comparison between genotypes. Note that the relative staining levels 
do not necessarily conform to a linear scale. Nonparametric tests were, therefore, used 
for comparison between genotypes. 
 
Pharmacological agents 
GABAB receptor agonist (±)-baclofen (referred to hence forward as baclofen) was 
purchased from Sigma-Aldrich. GABAA receptor antagonist (-)-bicuculline 
methochloride (referred to hence forward as bicuculline) and GABAB receptor 
antagonist CGP55845 was purchased from Tocris Bioscience (Bristol, UK). All other 
reagents used were of analytical grade and purchased from either Sigma-Aldrich 
Company Ltd. (Poole, Dorset, UK) or Fisher Scientific UK Ltd. (Loughborough, 
Leicestershire, UK).  
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Statistical analysis 
Data are expressed as mean ± standard error of the mean (SEM) and the n represents 
the number of different animals (see Results). Treatment effects over the time course 
were compared using paired t-test or repeated measures one-way ANOVA followed 
by Tukey’s multiple comparisons, where appropriate. Treatment effects among the 
three genotypes were analysed using ANOVA followed by Bonferroni’s post-hoc test 
or nonparametric tests, where appropriate. Statistical significance was taken as P < 
0.05. 
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Results 
Localisation of GABAB receptor subtypes in the molecular layer 
Previous studies show that transcripts for both 1a and 1b subunits are expressed in 
GCs and hilar neurons (Bischoff et al., 1999), but radioligand binding and 
immunohistochemical labelling of heteromeric GABAB receptors are mainly found in 
the hilus and the molecular layer, indicating predominant receptor expression on 
neuronal processes (Bischoff et al., 1999; Kulik et al., 2003). The mossy fibre 
terminals in the CA3 are immunopositive for the 1a subunit (Vigot et al., 2006; Guetg 
et al., 2009), showing selective trafficking of this subtype to GC axonal terminals. 
Conversely, GABAB(1b,2) receptors are probably expressed on dendrites of GCs in the 
molecular layer (Kulik et al., 2003) at their default dendritic localisation (Biermann et 
al., 2010). Here, we examined the anatomical localisation of the GABAB receptor 
subtypes in the DG in the 1a-/- and 1b-/- mice. Both anti-GABAB1 (B1) and anti-
GABAB2 (B2) antibodies were used because co-localisation of B1 and B2 subunits is 
essential for the assembly of heteromeric functional GABAB receptors (Kulik et al., 
2003; Gassmann et al., 2004; Vigot et al., 2006). B1 expression in the soma alone 
without B2 is indicative of B1 retention in the endoplasmic reticulum, as the binding 
of the B2 subunit enables surface expression of the heteromeric assembly (Margeta-
Mitrovic et al., 2000; Gassmann et al., 2004).  
 
The cellular architecture of the DG in the knockout brains were examined using the 
Nissl stain (Fig. 1A-C), and no apparent alteration from the WT was observed. Intense 
B1 immunostaining was found in the soma and proximal dendrites of hilar neurons 
and the neuropil of the molecular layer and GC layer in WT mice (Fig. 1D-F); B2 
staining was mainly found in the neuropil of the hilus and the molecular layer (Fig. 
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1G), indicating that the B1 and B2 subunits are co-localised in the neuropil of the 
hilus and the molecular layer for heteromeric receptor assembly (Kulik et al., 2003; 
Bischoff et al., 1999). Few neuronal cell bodies were stained in the molecular layer, in 
comparison to the number labelled by the Nissl stain (Fig. 1A-C), consistent with a 
low level of GABAB receptors in interneurons of the molecular layer (Bischoff et al., 
1999; Kulik et al., 2003). We, therefore, further analysed the subtype expression 
patterns in the molecular layer and the hilus.  
 
In the molecular layer of the WT mice, immunoreactivity for both B1 and B2 was 
more intense in a narrow band immediately adjacent to the GC layer in the inner 
molecular layer (IM) than the outer molecular layer (OM) (Fig. 1D, G and Fig. 2 A, 
B). In the 1a-/- mice, B1 and B2 staining was both reduced in the IM, but not the OM 
(Fig. 1E and H, and Fig. 2A and B, P < 0.05, Kruskal-Wallis test and Dunns post tests, 
n = 4 brains of each genotype), showing restricted co-localisation of the 1a and B2 
subunits in the IM, which form the GABAB(1a,2)  receptors. Correspondingly, in the 
1b-/- mice, B1 and B2 staining (Fig. 1F, I) was both significantly reduced in the OM 
(Fig. 2A and 2B, P < 0.05), but not the IM, showing predominance of the GABAB(1b,2)  
receptors in the OM. A schematic that depicts the localisation of the subunits in the 
molecular layer is shown in Fig. 2C, where the GABAB(1a,2)  receptors are 
concentrated in the IM, and the GABAB(1b,2) subtype dominates the OM. Enlarged 
sections (see the frame in Fig. 1E) that include the hilus and the enclosed blade of the 
molecular layer are shown in Fig 1M-R to illustrate the differential expression of 
GABAB(1a,2)  and GABAB(1b,2) receptors. The IM localisation of the axonal terminal-
preferring GABAB(1a,2) receptors may indicate the presence of presynaptic 
autoreceptors at hilar pathways innervating the proximal dendrite of GCs only. The 
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GABAB(1a,2) receptors may then inhibit hilar output, exerting a disinhibitory effect. 
Whereas, the GABAB(1b,2) receptors may be on GC dendrites in the OM (Kulik et al., 
2003), thereby mediating an inhibitory effect on GC output. 
 
Localisation of the GABAB receptor subtypes in the hilus 
Hilar neurons include a diverse population of GABAergic interneurons, which receive 
excitatory inputs from GC axons and project to the molecular layer to exert feedback 
inhibition on GC dendrites (Amaral et al., 2007). Previous studies show that GABAB 
receptors are expressed on GABAergic interneurons (Bischoff et al., 1999; Mott et al., 
1999; Kulik et al., 2003), but not the large-sized excitatory mossy cells found in the 
deep layer (Nahir et al., 2007). Hilar neurons were strongly labelled by the B1 
antibody, but B2 staining was distributed in the neuropil, highlighting a non-somatic 
localisation of heteromeric assemblies.  
 
The neuropil staining of B2 in the hilus (Fig. 1P-R) was significantly reduced in the 
1a-/- (Fig. 2D, P < 0.05, Kruskal-Wallis test and Dunns post-tests, n = 4 brains of 
each genotype), showing significant presence of the GABAB(1a,2) receptors on 
neuronal processes. Given their preferred localisation on axonal terminals, the 
GABAB(1a,2) receptors may include presynaptic heteroreceptors on GC axonal 
terminals innervating the hilus, similar to those expressed on mossy fibre terminals in 
the CA3 (Guetg et al., 2009). Activation of the GABAB(1a,2) heteroreceptors can 
inhibit excitatory inputs from GCs to reduce hilar neuron activity and induce 
disinhibition on GCs. Presumably, presynaptic GABAB(1a,2) heteroreceptors can also 
reduce excitatory inputs on the excitatory mossy cells (Nahir et al., 2007), resulting in 
further decreased excitation in the hilus.  
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Hilar neurons were intensely stained by the B1 antibody, showing somatic expression 
of the subunit. Hilar neurons at the border zone and the deep layer also differentially 
innervate the somatodendritic regions of GCs via proximal and distal pathways in the 
IM and OM, respectively (Freund & Buzsaki, 1996; Amaral et al., 2007). Given the  
co-localisation of 1a and B2 subunits in the IM, the GABAB(1a,2) receptors may be 
expressed on the axonal terminals of hilar border neurons. In correlation to the 
terminal expression, the 1a subunit may be abundantly expressed in the soma of these 
neurons due to retention in the endoplasmic reticulum, although its absence in the 
soma does not rule out the possibility of exclusive axonal terminal localisation as in 
the case of GCs. We found that the total number of B1-positive hilar neurons was 
reduced by 24.2 ± 6.6% in the 1a-/- mice (P < 0.001, n = 4 mice, Fig. 1E and 2E) and 
by 29.8 ± 3.1% (P < 0.001, n = 4 mice, Fig. 1F and 2E) in the 1b-/- mice, compared 
to the WT mice (a total of 49.3 ± 0.7 labelled neurons per section, n = 4 mice), 
showing that ~24% of the hilar neurons contain the 1a subunit only and ~30% the 1b 
only, while the rest (~46%) comprise both subunits. In addition, the number of 
neurons located in the border zone immediately adjacent to the GC layer was reduced 
by a greater extent in the 1a-/- mice (39.0 ± 9.8%, P < 0.001, n = 4, Fig. 2E), while 
the rest of hilar neurons in the deep layer was only significantly reduced in the 1b-/- 
mice (by 23.3 ± 7.5%, P < 0.01, n = 4, Fig. 2E), demonstrating prevalence of 1a-only 
neurons in the border zone and 1b-only ones in the deep layer. The relative 
distributions of the two isoforms are depicted in the Venn diagrams in Fig. 2F, where 
a relatively higher percentage of hilar border neurons express the 1a subunit only, and 
all deep-layer neurons express the 1b subunit.  
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Despite the relatively different somatic localisation of 1a and 1b subunit, most hilar 
neurons contain the 1a. The 1a-containing hilar border neurons included fusiform 
cells and pyramidal-shaped cells with prominent apical dendritic tuft extending to the 
GC layer, resembling the basket cells (Freund & Buzsaki, 1996; Amaral et al., 2007). 
These cells potentially innervate both perisomatic and proximal dendritic regions of 
GCs. However, as the 1a and B2 subunits were mainly co-localised in the IM, the 
GABAB(1a,2) receptors were then potentially only expressed at axonal terminals 
innervating the proximal dendrite. In addition, the 1a subunit was expressed in ~77% 
deep-layer neurons, but its expression level was low in the OM, indicating a 
deficiency in axonal terminal expression. Therefore, despite the abundance of somatic 
expression, the hilar neurons show differentially axonal terminal expression of the 1a 
subunit in the IM.  
 
Activation of GABAB (1a,2) receptors enhances GC population spikes to a greater 
extent  
The differential localisation of the GABAB receptor subtypes in the DG indicates their 
potentials to differentially modulate GC output at axonal terminal and dendritic sites 
of hilar pathways. We, therefore, studied the PP-GC synaptic transmission in the DG 
of the WT, 1a-/- and 1b-/- mice. Electrical stimulation in the outer two-thirds of the 
molecular layer activates the PP and evokes synaptic potentials in the GC dendrite 
and action potential in the cell body (Ault & Nadler, 1982; Burgard & Sarvey, 1991; 
Mott & Lewis, 1991; Mott et al., 1993). We recorded fEPSPs and PSs from the outer 
molecular layer and the GC layer, respectively, using a multi-electrode array (Fig. 
3A). The evoked potentials were blocked by the ionotropic glutamate receptor 
antagonist, CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) (20 µM, data not shown), 
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confirming the glutamatergic nature of the PP-GC synapses. Both the fEPSP slope 
and the PS amplitude increased with the stimulation intensity (10 - 110 µA with 10 
µA step) in all WT (n = 7), 1a-/- (n = 8) and 1b-/- (n = 7) mice. The input-output 
relationships did not differ between the genotypes (F[2,350] = 0.60, P > 0.05 for 
fEPSP slopes; F[2,240] = 0.89, P > 0.05 for PS amplitudes), nor did the relationship 
between the PS amplitude and the fEPSP slope (F[2,224] = 0.917, P > 0.05, Fig. 3B), 
demonstrating similar coupling between the excitatory inputs and GC firing in WT 
and GABAB1 isoform knockout mice in the single-pulse stimulation paradigm.  
  
Baclofen concentration-dependently (1 and 10 µM) augmented the PS in all mice (Fig. 
3C-E upper traces). An additional spike was induced following the initial spike in the 
PS (Fig. 3C-E, upper panels), indicating increased excitability of GCs due to reduced 
late-onset synaptic inhibition. The amplitude of the first spike was also enhanced at 10 
µM baclofen (Fig. 3G) by 129 ± 12 % (P < 0.05, n = 7) for WT; 128 ± 10% (P < 0.05, 
n = 8) for 1a-/- and 131 ± 10% (P < 0.05, n = 7) for 1b-/- mice. To include both spikes 
in the analysis, the area-under-the-curve (PS area) was measured and baclofen 
significantly increased the PS area in all genotypes (Fig. 3C-E lower panels, ### P < 
0.001 compared to its own baseline). Furthermore, the increase of the PS area was 
significantly greater in the 1b-/- mice than in the WT (P < 0.05) and 1a-/- mice (P < 
0.001, Fig. 3F), showing a larger effect mediated by the GABAB(1a,2) receptors. As the 
two receptor subtypes do not differ pharmacologically (Vigot et al., 2006), the greater 
effect by the GABAB(1a,2) receptors may reflect their relative localisation in the hilar 
inhibitory pathways (Fig. 1 and 2).  
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Despite the enhancement in PS amplitude and PS area, the initial slope of the fEPSPs 
recorded in the OM was not enhanced by baclofen (Fig. 3I, F[1,19] = 2.3, P > 0.05, 7 
WT, 10 1a-/- and 7 1b-/- mice), nor was the initial slope of the positive fEPSP in the 
PS (Fig. 3H, F[3,71] = 2.1, P > 0.05), demonstrating a lack of GABAB 
heteroreceptors on the excitatory axonal terminals of the PP in the mouse DG. This is 
in agreement with the lack of presynaptic GABAB receptors on PP terminals in the 
stratum lacunosum moleculare of the mouse CA1 (Price et al., 2008). The GABAB 
receptor-selective antagonist, CGP55845 (1 µM), also failed to affect the fEPSP slope 
(Fig. 3I, F[1,16] = 2.6, P > 0.05, WT, n = 7; 1a-/-, n = 10 and 1b-/-, n = 7 mice), 
showing a lack of endogenous GABAB receptor activation upon single-pulse PP 
stimulation. The enhanced PS, therefore, demonstrates disinhibitory effects of the 
GABAB receptors. The additional spike in the PS further indicates reduced feedback 
inhibition, consistent with the intense expression of GABAB receptors in the hilus.  
  
GABAA receptor blockade prevents baclofen-induced disinhibition and reveals an 
inhibition by GABAB(1b,2) receptors only  
To confirm that the potentiation of the PS is due to disinhibition, we examined effects 
of baclofen in the presence of GABAA receptor antagonist, bicuculline (10 µM), 
because the GABAA receptor blockade is expected to abolish feedback synaptic 
inhibition and hence baclofen-induced disinhibition via reduced GABA release. 
Bicuculline induced multiple spiking in the PSs in all slices, showing facilitated 
action potential generation in GCs resulting in a spike train. As a result, the PS area 
was significantly increased (Fig. 4A – C, PS area, P < 0.001 compared to baseline). In 
the presence of bicuculline, baclofen (10 µM) failed to enhance the PS in any 
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genotype (P > 0.05), confirming that the PS enhancement was due to GABAA 
receptor-dependent disinhibition.  
  
However, in the presence of GABAA blockade, baclofen reduced the PS area in WT 
and 1a-/- mice (Fig. 4A - D, P < 0.001 compared to baseline, n = 7 for WT, n = 6 for 
1a-/-), but not 1b-/- mice (P > 0.05, n = 6). The amplitude of the first spike in the PS 
was also reduced but not the initial slopes of the fEPSP, indicating a direct 
postsynaptic inhibition on GCs, but not a pre-terminal inhibition of the PP-GC 
transmission. The GABAB(1b,2) receptors, therefore, also mediate a postsynaptic 
inhibition at GC dendrites (Vigot et al., 2006; Tiao et al., 2008; Biermann et al., 
2010). This additional inhibitory effect is in contrast to the exclusive disinhibitory 
effects of GABAB(1a,2) receptors, reflecting their differences in anatomical localisation. 
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Discussion 
We show for the first time that GABAB receptor subtypes differentially modulate 
synaptic inhibition on GCs at different localisations of the hilar pathways in the DG. 
The axonal terminal-preferring GABAB(1a,2)  receptors are predominantly located in 
the neuropil of the inner molecular layer and the hilus, and in hilar border neurons. 
Activation of this subtype exclusively decreases GABAA receptor-mediated synaptic 
inhibition, thereby indicating presynaptic reduction of excitatory inputs to the hilus 
and also inhibition of hilar outputs. The dendrite-preferring GABAB(1b,2)  receptors 
dominate the outer molecular layer and deep-layer hilar neurons. This subtype may, 
therefore, mediate the disinhibitory and inhibitory effects on GCs via dendritic 
inhibition of hilar neurons and GCs, respectively.  The GABAB(1a,2)  receptors are also 
more effective at augmenting GC output, highlighting a greater role of these 
presynaptic receptors in gating spike transmission from the DG to the hippocampus 
for spatial and pattern learning.  
  
The use of 1a-/- and 1b-/- mice isolates GABAB(1a,2)  and GABAB(1b,2)  receptor 
expression without altering the cellular architecture of the DG (Fig. 1). Previous 
studies using these mice have revealed differential roles of the GABAB receptor 
subtypes in synaptic circuitry (Ulrich & Bettler, 2007; Pinard et al., 2010). Most 
notably, the GABAB(1a,2) receptors are the exclusive presynaptic receptors on 
glutamatergic and GABAergic synapses, trafficked by the “sushi” domains on the 1a 
subunit (Tiao et al., 2008; Biermann et al., 2010), while the GABAB(1b,2)  predominant 
dendritic receptors (Vigot et al., 2006; Perez-Garci et al., 2006; Ulrich et al., 2007; 
Guetg et al., 2009). The differential localisation of the subtypes in synaptic 
compartments enables them to differently modulate synaptic functions and cognitive 
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behaviours. Here, we evaluated the subtypes in modulating synaptic inhibition in the 
DG.  
 
Disinhibitory and inhibitory roles of  GABAB(1b,2) receptors in the DG 
Baclofen-induced enhancement of GC activity has been attributed to decreased 
inhibitory actions from hilar pathways (Burgard & Sarvey, 1991; Mott & Lewis, 1991; 
Mott et al., 1993). GABAB receptors are highly expressed on hilar interneurons 
(Bischoff et al., 1999; Mott et al., 1999; Kulik et al., 2003). Activation of these 
receptors hyperpolarises the membrane potential and decreases hilar neuronal 
excitability (Mott et al., 1999), which, in turn, reduces GABA release and synaptic 
inhibition on GCs. We demonstrate that selective activation of the GABAB(1b,2) 
receptor subtype in the 1a-/- mice enhances GC PSs via disinhibition (Fig. 3 and 4), 
consistent with activation of dendritic GABAB(1b,2) receptors on hilar neurons (Fig. 1 
and 2). Furthermore, we show that GABAB(1b,2) receptors also mediate a direct 
inhibition on GCs during GABAA receptor blockade, agreeing with a hyperpolarising 
action at the extrasynaptic compartments of  GC dendrites in the outer molecular layer 
(Kulik et al., 2003). Therefore, dendritic GABAB(1b,2) receptors on hilar neurons and 
GCs mediate disinhibition and inhibition of GC output, respectively. 
 
Exclusively disinhibitory roles of GABAB(1a,2) receptors in the DG 
More importantly, this study reveals that the axonal terminal-preferring GABAB(1a,2) 
receptors collectively mediate disinhibition of the GCs without inhibition of the PP-
GC transmission. In the molecular layer where GC dendrites are located, the 
GABAB(1a,2)  receptors are densely expressed in a narrow band of the inner molecular 
layer immediately adjacent to the GCs. Given their preferential presynaptic 
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localisation and the exclusive disinhibitory effects, the GABAB(1a,2) receptors are 
envisaged to be on GABAergic axonal terminals acting as autoreceptors. Activation 
of these autoreceptors can effectively decrease GABAergic inhibition on proximal 
dendrites that shunts dendritic potentials (Ben-Ari et al., 2005), consistent with the 
enhanced GC output (Fig. 3). In addition, disinhibition via presynaptic autoreceptors 
may be stronger than postsynaptic hyperpolarisation, which can be easily overcome 
by strong depolarisation on hilar neurons (Mott et al., 1999), further supporting a 
greater disinhibitory effect of GABAB(1a,2)  receptors.  
 
Hilar interneurons are activated by GC axons, inducing feedback inhibition onto GC 
dendrites in the molecular layer (Freund & Buzsaki, 1996; Amaral et al., 2007). 
Given their exclusive disinhibitory roles, the GABAB(1a,2)  receptors expressed in the 
neuropil of the hilus (Fig. 1 and 2) are potentially presynaptic heteroreceptors on GC 
axonal terminals innervating hilar neurons, similar to those expressed at mossy fibre 
terminals in the CA3 (Vigot et al., 2006; Guetg et al., 2009). Activation of these 
receptors reduces excitatory inputs to hilar neurons, decreases hilar neuron activity 
and, subsequently, feedback inhibition on GC dendrite, manifesting a disinhibitory 
action that can synergise with the autoreceptors in the inner molecular layer. If the 
GABAB(1a,2)  receptors were autoreceptors at inhibitory terminals in the hilus, their 
activation would increase hilar neuron activity and enhance feedback inhibition on 
GCs, opposite to what was observed experimentally. Therefore, GABAB(1a,2)  
receptors in the neuropil of the hilus are potentially heteroreceptors on GC axonal 
terminals, mediating disinhibition in synergy with the autoreceptors. 
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Given that the majority of hilar neurons express the 1a subunit, it is potentially 
possible that the GABAB(1a,2)  autoreceptors in the inner molecular layer are on axonal 
terminals of hilar neurons. The 1a-containing hilar neurons in the border zone include 
basket cells and fusiform cells, and they preferentially project to perisomatic and 
proximal dendritic regions of the GCs (Freund & Buzsaki, 1996; Amaral et al., 2007), 
thereby having the potential to traffick GABAB(1a,2) receptors to axonal terminals in 
the GC and the inner molecular layer. However, the restricted localisation of 
GABAB(1a,2) receptors in the inner molecular layer suggests that only a subpopulation 
of the axons that project to the proximal dendrite of GCs may express the 
autoreceptors. 
 
Heterogeneity of 1a expression between the soma and the terminal is more 
pronounced in deep-layer neurons, which, including HIPPs (Hilar Perforant Path 
related cells) (Han et al., 1993), preferentially terminate on distal dendrites of GCs in 
the outer molecular layer. Despite that the majority of deep-layer hilar neurons 
contain both 1a and 1b subunits, a low level of GABAB(1a,2)  expression is found in the 
outer molecular layer. This indicates that these cells do not efficiently traffick the 
subunit to terminals. Potentially, axonal trafficking can be limited by the availability 
of intracellular binding proteins for “sushi” domains (Biermann et al., 2010). 
Therefore, hilar neurons may regulate the spatial expression of autoreceptors on axon 
terminals across the molecular layer to selectively modulate inhibition on proximal 
dendrite of GCs. 
 
Endogenous activation of GABAB receptor subtypes  
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While the blockade of GABAA receptors by the antagonist, bicuculline, markedly 
enhanced the PS (Fig. 4), showing significant endogenous GABA release, GABAB 
receptors were not activated by the single-pulse PP stimulation. The selective 
antagonist, CGP55845, did not affect the PS or the fEPSP, probably because GABAB 
receptors are predominantly located extrasynaptically in the DG (Kulik et al., 2003), 
only activated by “spillover” of GABA under synchronised and/or high frequency 
activation (Scanziani, 2000). The GABAB(1a,2) autoreceptors concentrated in the inner 
molecular layer can potentially be activated by local release of GABA, producing 
activity-regulated gating of GC output. 
 
Dendritic GABAB receptors in the outer molecular layer are, however, activated by 
GABA released from en passant axonal varicosities of neurogliaform cells 
(Armstrong et al., 2011), a subtype of GABAergic interneurons displaying extensive 
axonal arborisations which form non-synaptic contacts with other cells (Tamas et al., 
2003; Olah et al., 2009). Neurogliaform cells are present in the outer two-thirds of the 
molecular layer and PP stimulation activates these cells and induces GABAA and 
GABAB inhibitory postsynaptic currents on GCs (Armstrong et al., 2011). Although 
the GABAB antagonist had no effect on the PS, local receptor activation may 
modulate dendritic NMDA receptor activity and calcium signals (Chalifoux & Carter, 
2010) and regulate synaptic plasticity. The two GABAB subtypes in the molecular 
layer are, therefore, potentially activated by different forms of endogenous GABA 
release. 
  
Disinhibitory and inhibitory roles of GABAB(1a,2)  receptors in the hippocampal tri-
synaptic circuit 
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We also reveal a lack of presynaptic GABAB heteroreceptors on PP terminals in the 
mouse DG. GABAB(1a,2) receptors in the DG are, therefore, particularly important for 
disinhibition,  which enhances GC output and spike transmission to the hippocampus. 
Conversely, GABAB(1a,2) receptors in CA3 and CA1 areas are mainly presynaptic 
heteroreceptors inhibiting glutamate release and CA3 and CA1 outputs (Vigot et al., 
2006; Guetg et al., 2009). The lack of GABAB(1a,2) receptors, therefore, alters the 
dynamic range of signal transfer in the tri-synaptic circuits between the PP and the 
CA1, resulting in decreased proportion of silent synapses, impaired long-term 
potentiation in the CA1 (Vigot et al., 2006; Guetg et al., 2009) and deficits in novel 
object recognition (Vigot et al., 2006; Jacobson et al., 2007). Furthermore, rapid 
changes in the expression of presynaptic GABAB receptors in hippocampal mossy 
fibre and CA1 inhibitory terminals have been demonstrated following kindling, 
indicating that the axonal trafficking of 1a subunit may be an important regulatory 
mechanism in epileptogenesis. 
 
In conclusion, due to the difference in their default synaptic localisation, the axon 
terminal-preferring GABAB(1a,2) and dendrite-preferring GABAB(1b,2) receptor subtypes 
are distinctly expressed in hilar inhibitory pathways and GCs and differentially 
modulate GC output. By regulating subunit composition and expression in neuronal 
circuits, GABAB receptor subtypes modulate a variety of behavioural states. 
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Figure legend 
Figure 1. The distribution of GABAB receptor subunits in the DG of 1a-/- and 1b-/- 
mice. A-C: The Nissl stain in the DG shows no significant anatomical differences for 
cell populations in the GC layer, molecular layer (Mol) and the hilus (H) between the 
wild-type (WT), 1a-/- and 1b-/- mice. D-F: GABAB1 immunolabelling in the DG 
using an immunoperoxidase method reveals high intensity staining in the cell bodies 
and proximal dendrites of hilar neurons, and in the neuropil of the inner molecular 
layer (IM, see G). The number of immunopositive hilar neurons is lowered in the 1a-/- 
(E) and 1b-/- mice (F). The neuropil staining is reduced in the IM in the 1a-/- mice 
and the outer molecular layer (OM, see G) in the 1b-/- mice. G-I: GABAB2 
immunoperoxidase labelling in the DG show that the relative neuropil staining 
intensities in the IM and the OM were reduced in the 1a-/- (H) and the 1b-/- mice (I), 
respectively. J-L: Examples of negative control sections processed without the 
addition of GABAB1 or GABAB2 antibodies show low levels of background staining. 
The scale bar for all sections (200 µm) is shown in A. M-R, enlarged sections from D-
I (see the frame in E) showing the immunostaining patterns in the molecular layer and 
hilar neurons. 
 
Figure 2. Comparison of GABAB receptor subtype expression in the molecular layer 
(A-C) and hilar neurons (D-F). A. The relative intensity scores of B1 immunostaining 
were significantly reduced in the IM in the 1a-/- mice (*), and in the OM only in the 
1b-/- mice (*) compared to the WT. B. The relative intensity scores of B2 
immunostaining were significantly reduced in the IM in the 1a-/- (*) and the OM in 
the 1b-/- mice (*). The scores range from 0 (no staining) to 3 (the highest intensity) 
and were used for all sections the brain processed simultaneously. Each score was the 
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mean from 8 – 20 sections. Nonparametric Kruskal-Wallis test and Dunns post tests 
were performed. C. A schematic of the relative co-localisation of 1a, 1b and B2 
subunits in the molecular layer. D. The relative intensity scores of B2 immunostaining 
were significantly reduced in the hilus in the 1a-/- mice (* P < 0.05, nonparametric 
Kruskal-Wallis test and Dunns post tests). E. The total number of immunopositive 
hilar neurons (Total) was significantly decreased in the 1a-/- (***) and 1b-/- mice 
(***). The number of neurons at the hilus-GC border zone (Border) also significantly 
decreased in the 1a-/- (***) and 1b-/- mice (*). However, the number of hilar neurons 
in deep layers was only significantly lower in the 1b-/- mice (*). The data were mean 
counts from 8 – 20 sections per brain. Two-way ANOVA and Bonferroni’s multiple 
comparison tests were used (* P < 0.05, ** P < 0.01, *** P < 0.001). N = 4 brains of 
each genotype. F. Venn diagrams illustrate the relative percentages of hilar neurons 
containing 1a, 1b or both in the border zone and the deep layer, respectively.  
 
Figure 3. The GABAB receptor agonist, baclofen (Bac), enhances the PS in the DG. A. 
A schematic of the multi-electrode positions in the DG for simultaneous recordings of 
the fEPSPs and the PSs. Electrical stimulation was applied to an electrode in the outer 
two-thirds of the molecular layer (Mol) and evoked fEPSPs were recorded in the outer 
molecular layer and PSs adjacent to the GC layer. B. fEPSPs and PSs were 
simultaneously recorded at stimulation intensities ranging from 10 to 110 µA with a 
10 µA incremental step. The PS amplitude and the fEPSP slope were normalised and 
plotted at all stimulation intensities. The relationships between the PS amplitude and 
the fEPSP slope are similar between the wild-type and the 1a-/- and 1b-/- mice 
(F[2,224] = 0.917,  p > 0.05), indicating unaltered coupling between the excitatory 
synaptic transmission and the GC excitability. C-E. Bath application of 10 µM Bac 
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significantly increased the PS areas in all genotypes (### P < 0.001, compared to 
baseline). The effects were rapidly reduced by CGP55845, showing GABAB receptor 
activation. F. Bac concentration-dependently increased the PS area in all mice (***, 
F[3,71] = 84.6). At 10 µM, Bac induced a significantly larger effect in the 1b-/- mice 
compared to the wild-type (*) and 1a-/- mice (***). Bac also concentration-
dependently increased the PS amplitude in all genotypes (G, ***, F[3,71] = 17.6). H 
and I. The fEPSP slopes were not altered by the application of Bac or CGP55845 in 
all genotypes (G, F[1,15] = 0.3, P > 0.05, I, F[3,71] = 2.1, P > 0.05). Repeated-
measure two-way ANOVA followed by Bonferroni post-test was used for comparison 
(* P < 0.05, ** P < 0.01 and ***P < 0.001).  
 
Figure 4. The baclofen-induced enhancement of the PS is GABAA receptor-dependent. 
A-C. The GABAA receptor antagonist, bicuculline (10 µM), induced multiple spikes 
in the PSs and significantly (***P < 0.001, compared to the baseline) increased the 
PS area, showing increased GC excitability. In the presence of bicuculline, baclofen 
(Bac) failed to increase the PS area because of the blockade of GABAA receptors. 
However, Bac significantly decreased the PS area in wild-type and 1a-/- mice (### P 
< 0.001, compared to bicuculline treatment), but not in 1b-/- mice, showing an 
inhibitory effect mediated by GABAB(1b,2) receptors. CGP55845 reduced the effect of 
Bac, confirming GABAB receptor activation. A comparison of Bac-induced inhibition 
between genotypes is shown in D (*** P < 0.001, one-way ANOVA followed by 
Tukey’s test).  
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